|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$101
|
$274B |
4.2x |
9.4x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.6x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€86
|
$130B |
2.5x |
8.3x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£18
|
$116B |
2.7x |
8.0x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 182
|
$67.5B |
4.3x |
12.6x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€243
|
$54.7B |
6.6x |
22.0x |
|
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 20
|
$8.4B |
5.1x |
-58.7x |
|
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 232
|
$8.0B |
8.3x |
27.2x |
|
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 47
|
$7.9B |
N/A |
N/A |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$97
|
$6.7B |
2.2x |
-5.6x |
|
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$221
|
$6.5B |
69316.3x |
N/A |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$25
|
$6.1B |
3.0x |
-1.9x |
|
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$48
|
$4.6B |
N/A |
N/A |
|
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2520
|
$4.5B |
10.6x |
32.4x |
|
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.5B |
5.2x |
14.3x |
|
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 46
|
$3.3B |
10.5x |
65.4x |
|
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 54500
|
$2.5B |
6.0x |
-81.9x |
|
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 16
|
$2.5B |
6.0x |
21.3x |
|
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 9089
|
$2.5B |
N/A |
N/A |
|
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 12
|
$2.5B |
6.9x |
24.8x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$26
|
$2.5B |
9.9x |
-6.9x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.4B |
23.6x |
N/A |
|
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 45
|
$1.9B |
8.3x |
-78.2x |
|
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 192
|
$1.9B |
2.0x |
5.4x |
|
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 13
|
$1.8B |
10.2x |
43.2x |
|
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 23
|
$1.7B |
10.6x |
11.7x |
|
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 16565
|
$1.5B |
N/A |
N/A |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$19
|
$1.5B |
191.5x |
-6.9x |
|
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€31
|
$1.4B |
N/A |
N/A |
|
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 81
|
$1.4B |
7.4x |
20.1x |
|
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 21
|
$1.3B |
7.3x |
24.6x |
|
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$28
|
$1.3B |
408.2x |
-5.0x |
|
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 14
|
$1.2B |
8.5x |
14.5x |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$1.1B |
416.1x |
-7.3x |
|
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 6
|
$1.0B |
32.6x |
-28.5x |
|
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$57
|
$984M |
20.9x |
-6.8x |
|
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$44
|
$979M |
5.0x |
-29.4x |
|
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$925M |
2.8x |
34.8x |
|
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$883M |
10.4x |
-44.0x |
|
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 16
|
$864M |
5.5x |
10.9x |
|
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 27
|
$860M |
3.6x |
11.7x |
|
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$807M |
4.1x |
-17.4x |
|
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$775M |
14.0x |
-3.9x |
|
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$728M |
11286.2x |
N/A |
|
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 3
|
$727M |
3.9x |
N/A |
|
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$5
|
$719M |
6.4x |
-6.9x |
|
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$7
|
$600M |
0.6x |
1.8x |
|
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$589M |
N/A |
N/A |
|
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$566M |
N/A |
N/A |
|
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$562M |
495.6x |
-1.8x |
|
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 23
|
$562M |
189.6x |
-28.7x |
|
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$540M |
6.2x |
-65.8x |
|
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$536M |
11.0x |
-8.3x |
|
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 398
|
$507M |
N/A |
N/A |
|
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$466M |
40.7x |
-0.9x |
|
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 6
|
$453M |
N/A |
-7.2x |
|
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$427M |
N/A |
N/A |
|
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 395
|
$425M |
1.9x |
N/A |
|
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 40
|
$376M |
19.5x |
-1311.5x |
|
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$363M |
72.8x |
N/A |
|
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 23
|
$345M |
1.9x |
8.0x |
|
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 19
|
$307M |
N/A |
N/A |
|
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$296M |
5513701.7x |
-11.1x |
|
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 23
|
$289M |
1.5x |
6.9x |
|
Enlivex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$241M |
N/A |
N/A |
|
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$198M |
7812.8x |
-1.1x |
|
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$196M |
N/A |
-4.4x |
|
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$185M |
1.3x |
N/A |
|
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$167M |
47860.9x |
-0.8x |
|
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$159M |
269374.7x |
-6.4x |
|
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$157M |
21.4x |
N/A |
|
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$155M |
14.6x |
-4.1x |
|
Kyverna Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$148M |
N/A |
-0.9x |
|
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 10350
|
$147M |
N/A |
N/A |
|
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$144M |
N/A |
N/A |
|
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 31
|
$143M |
N/A |
N/A |
|
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€5
|
$133M |
2.5x |
16.0x |
|
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$132M |
41.6x |
-7.1x |
|
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 17
|
$128M |
N/A |
N/A |
|
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$125M |
N/A |
N/A |
|
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$125M |
N/A |
-4.9x |
|
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$124M |
N/A |
N/A |
|
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 15
|
$120M |
N/A |
N/A |
|
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$113M |
N/A |
N/A |
|
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$101M |
17.5x |
N/A |
|
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$100M |
N/A |
N/A |
|
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$98.0M |
1000.9x |
N/A |
|
TuHURA Biosciences
|
United States of America |
Vaccines & Immunotherapies
|
$2
|
$95.8M |
N/A |
N/A |
|
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$13
|
$93.4M |
0.8x |
3.0x |
|
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$1
|
$92.3M |
1.3x |
-0.4x |
|
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$91.1M |
N/A |
-0.5x |
|
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$88.0M |
N/A |
-3.6x |
|
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$83.2M |
N/A |
N/A |
|
Shattuck Labs
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$81.0M |
52.8x |
-1.6x |
|
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 2
|
$80.2M |
N/A |
N/A |
|
SAB Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$71.8M |
733.8x |
N/A |
|
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$64.1M |
N/A |
N/A |
|
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$59.9M |
19.6x |
-1.6x |
|
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$58.0M |
6.6x |
N/A |
|
Prescient Therapeutics
|
Australia |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
AUD 0
|
$49.8M |
N/A |
N/A |